---
title: A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults
  With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation
date: '2023-11-01'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37914144/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231102180753&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Single-agent cisplatin can be considered as the standard
  chemotherapy regimen for older HNSCC patients who can tolerate cisplatin. Cumulative
  cisplatin doses are prognostically relevant also in older HNSCC ...'
disable_comments: true
---
CONCLUSIONS: Single-agent cisplatin can be considered as the standard chemotherapy regimen for older HNSCC patients who can tolerate cisplatin. Cumulative cisplatin doses are prognostically relevant also in older HNSCC ...